Nerve block for knee pain relief

A Flinders team has led a clinical trial to show how patients can receive temporary pain relief by blocking nerves around knee osteoarthritis sites.

The results, just published in high-ranking Wiley journal Arthritis & Rheumatology, trialled the method in a randomised trial of 59 patients using an ultrasound-guided genicular nerve block or a placebo injection. Participants recorded their pain on a scale of 0 to 10 at baseline then after two, four, eight and 12 weeks.

The study found patients with knee osteoarthritis may experience short-term pain relief from genicular nerve blocks or locally injected anaesthetics that block nerves around the knee joint, says lead researcher Professor Michael Shanahan, from Flinders University and the Southern Adelaide Local Health Network Rheumatology Unit at Flinders Medical Centre.

Professor Michael Shanahan, Flinders Medical Centre clinician.

While the benefits of the relief diminished over time, most patients who received the blocks felt they had improved or greatly improved from baseline during the follow-up period.

The scores recorded for nerve block versus placebo at baseline, weeks 2, 4, 8, and 12 were: 6.2 versus 5.3, 2.7 versus 4.7, 3.2 versus 5.1, 3.9 versus 4.9, and 4.6 versus 5.1, respectively.

“This study demonstrates that genicular nerve block is an effective short-term therapy for pain management in people with knee osteoarthritis,” says Professor Shanahan.

“We think it may be a useful treatment option for this group of people, in particular those waiting for, or wishing to defer surgery.”

Osteoarthritis of the knee is a major public health issue where treatment is often problematic, he says.

“Genicular nerve block (GNB) is a novel therapeutic intervention that may help to manage the pain from knee OA.”

/Public Release. This material from the originating organization/author(s) may be of a point-in-time nature, edited for clarity, style and length. The views and opinions expressed are those of the author(s).View in full here.